Satellos Bioscience (MSLE) Research & Development (2025 - 2026)
Satellos Bioscience's (MSLE) quarterly Research & Development came in at $7.3 million in Q1 2026, up 60.94% year-on-year from $4.5 million in Q1 2025, and up 60.94% on a QoQ basis from $4.5 million in Q1 2025.
Satellos Bioscience (MSLE) Research & Development (2025 - 2026) Analysis & Trends
Satellos Bioscience (MSLE) has 2 years of Research & Development data on file, last reported at $7.3 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - | -17.94 Mn |
| 2 | Nanobiotix | 1,916.61 Bn | 1,916.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 1.46 Mn |
| 4 | BeOne Medicines | 471.65 Bn | 466.85 Bn | 1.35 Bn | 541.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.94 Bn | 114.69 Bn | 2.59 Bn | 961.60 Mn |
| 6 | Regeneron Pharmaceuticals | 69.85 Bn | 61.09 Bn | 3.31 Bn | 1.54 Bn |
| 7 | Belite Bio | 63.06 Bn | 63.06 Bn | - | 15.66 Mn |
| 8 | Argenx Se | 55.74 Bn | 50.56 Bn | 1.41 Bn | 1.37 Bn |
| 9 | Revolution Medicines | 37.48 Bn | 37.48 Bn | - | 343.97 Mn |
| 10 | Satellos Bioscience | 175.69 Mn | 175.69 Mn | - | 7.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.31 Mn |
| Mar 31, 2025 | 4.54 Mn |